SFM

[anonymous]

O7 will be hard. It didn't outperform maxalt alone at 2 hours... But that might not matter since pple cycle drugs like cray here

I'm not so worried about this one. I spoke to the former godfather at Merck, the guy was employee 5 before the drug was approved and worked on it all the way through patent expiry. There are many ways to sell this.....take early, proximal absorption, focus on reduction of associated symptoms, 30 minute response, and rescue med for preventative mabs. Just focus on the Riza part.

 

[anonymous]

Such trash to post people’s bonus payment amount. Who are we? Purdue Pharma?

Really curious about her motivation. Is that supposed to inspire me?
The level of phoniness with her is really something.

 

[anonymous]

I'm not so worried about this one. I spoke to the former godfather at Merck, the guy was employee 5 before the drug was approved and worked on it all the way through patent expiry. There are many ways to sell this.....take early, proximal absorption, focus on reduction of associated symptoms, 30 minute response, and rescue med for preventative mabs. Just focus on the Riza part.

Ridiculous. There are rescue mabs on the market. But anyone who knows wtf they’re talking about calls them anti-cgrp. Your guy is dated and giving you bad info. It’s a race out here to get through any step thru therapy (if there are any at all because the new drugs are that good) to get to what they want. That drug is going to fall flat and no one in there right mind would prescribe that old technology as a combo bs for a higher branded price. Absolutely insane that anyone would want to sell this.

 

[anonymous]

Ridiculous. There are rescue mabs on the market. But anyone who knows wtf they’re talking about calls them anti-cgrp. Your guy is dated and giving you bad info. It’s a race out here to get through any step thru therapy (if there are any at all because the new drugs are that good) to get to what they want. That drug is going to fall flat and no one in there right mind would prescribe that old technology as a combo bs for a higher branded price. Absolutely insane that anyone would want to sell this.

The bottom line is that the drug doesn't work very well and doesn't have a compelling reason as to why anyone should use it. The data doesn't even support the its supposed value proposition very well. This drug will get completely drowned out by the branded CGRPs. It is a crappier version of treximet and will fail just as badly.

 

[anonymous]

Stock is at 100. Just stop already, sales are flying.

 

[anonymous]

Stock is at 100. Just stop already, sales are flying.

All stocks are rising. Flat out this place is a ponzi scheme. You know it.

 

[anonymous]

All stocks are rising. Flat out this place is a ponzi scheme. You know it.

My sales are soaring because I'm a hustler baby. Look for me on Netflix Friday night. I'll be ringside at the Tyson fight with my customers!!

 

[anonymous]

Couldn’t agree more. It’s gross! Obviously SFM is projecting onto the salesforce the sad truth about her life, money above all else, family, friends, colleagues and of course suffering patients. I would say she should be embarrassed, but that would imply that a narcissist is capable of human emotion.

She is highlighting the top earners to provide talking points for the RBD’s forced to recruit anyone desperate enough and dumb enough to come to Axsome after reading this thread.